The Not-So-Divine Right of Shareholders?

Justin Hibbard

The NY Times reports today that the SEC plans to accuse hedge fund Perry Capital of disclosure violations in the 2004 takeover of King Pharmaceuticals. This could be an important warning to some of the more aggressive hedge funds.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.